Growth Metrics

Edwards Lifesciences (EW) Total Liabilities (2016 - 2026)

Edwards Lifesciences has reported Total Liabilities over the past 17 years, most recently at $3.4 billion for Q4 2025.

  • For Q4 2025, Total Liabilities rose 12.27% year-over-year to $3.4 billion; the TTM value through Dec 2025 reached $3.4 billion, up 12.27%, while the annual FY2025 figure was $3.4 billion, 12.27% up from the prior year.
  • Total Liabilities for Q4 2025 was $3.4 billion at Edwards Lifesciences, up from $3.1 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $3.4 billion in Q3 2024 and troughed at $2.4 billion in Q3 2022.
  • A 5-year average of $2.7 billion and a median of $2.6 billion in 2021 define the central range for Total Liabilities.
  • Biggest five-year swings in Total Liabilities: grew 27.09% in 2024 and later dropped 8.71% in 2025.
  • Year by year, Total Liabilities stood at $2.7 billion in 2021, then dropped by 6.78% to $2.5 billion in 2022, then increased by 6.36% to $2.6 billion in 2023, then increased by 13.19% to $3.0 billion in 2024, then rose by 12.27% to $3.4 billion in 2025.
  • Business Quant data shows Total Liabilities for EW at $3.4 billion in Q4 2025, $3.1 billion in Q3 2025, and $2.9 billion in Q2 2025.